This review highlights the lack of robust evidence for optimal anticoagulant dosing at extremes of body weight and the potential risks of over- or under-exposure with fixed-dose DOACs.
No takes yet. Share an insight, caveat, or question.
Caution warranted dosing DOACs at weight extremes due to exposure risks; leaves open optimal regimens pending dedicated trials.
McCaughan et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: